PENTASA 1 g, suppository 14 suppositories
Brand page: Pentasa (mesalazine) — all forms and strengths in France
Active ingredients: Mesalazine
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Suppository14 suppositoriesrectale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- PENTASA 1 g, suppositoire
- Pharmaceutical form
- suppositoire
- Route of administration
- rectale
- Presentation description
- plaquette(s) thermoformée(s) aluminium PVC-Aluminium de 14 suppositoire(s)
- Marketing authorisation holder
- FERRING (FRANCE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Feb 2021
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69694541CIP73018171CIP133400930181713Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉSALAZINEsuppositoire | 1 g · un suppositoire | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.